Survivin phosphorylation and M-phase promoting factor in oral carcinogenesis

Histology and Histopathology

Volumn 22, Issue 10-12, 2007, Pages 1241-1249

  Pannone, G ^a   Bufo, P ^a   Serpico, R ^b   Rubini, C ^c   Zamparese, R ^a   Corsi, F ^a   Pedicillo, M C ^a   Staibano, S ^d   De Rosa, G ^d   Lo Muzio, Lorenzo ^a,e  

^a UNIVERSITY OF FOGGIA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e NONE   (Italy)

Author keywords

Apoptosis; Cyclin B1; MPF; OSCC; p survivin; p34cdc2; Survivin

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE 1; MATURATION PROMOTING FACTOR; SURVIVIN; BIRC5 PROTEIN, HUMAN; CYCLIN B; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PRECANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PHOSPHORYLATION;

CARCINOMA, SQUAMOUS CELL; CDC2 PROTEIN KINASE; CYCLIN B; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MATURATION-PROMOTING FACTOR; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PHOSPHORYLATION; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 34748856831     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Altznauer F., Martinelli S., Yousefi S., Thurig C., Schmid I., Conway E.M., Schoni M.H., Vogt P., Mueller C., Fey M.F., Zangemeister-Wittke U. and Simon H.U. (2004). Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 199, 1343-1354.
2. Ambrosini G., Adida C., Sirugo G. and Altieri D.C. (1998). Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem. 273, 11177-11182.
3. Bedi G.C., Westra W.H., Gabrielson E., Koch W. and Sidransky D. (1996). Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 56, 2484-2487.
4. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., Corio R., Lee D., Greenberg B., Koch W. and Sidransky D. (1996). Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56, 2488-2492.
5. Campisi G. and Margiotta V. (2001). Oral mucosal lesions and risk habits among men in an Italian study population. J. Oral Pathol. Med. 30, 22-28.
6. Carey T.E. (1996). Field cancerization: are multiple primary cancers monoclonal or polyclonal? Ann. Med. 28, 183-188.
7. Chen Y.K., Hsue S.S. and Lin L.M. (2005). Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas. Arch. Oral Biol. 50, 593-598.
8. Clute P. and Pines J. (1999). Temporal and spatial control of cyclin B1 destruction in metaphase. Nat. Cell Biol. 1, 82-87.
9. Forrest A. and Gabrielli B. (2001). Cdc25B activity is regulated by 14-3-3. Oncogene 20, 4393-401.
10. Fortugno P., Wall N.R., Giodini A., O'Connor D.S., Plescia J., Padgett K.M., Tognin S., Marchisio P.C. and Altieri D.C. (2002). Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. 115, 575-585.
11. Hoffman W.H., Biade S., Zilfou J.T., Chen J. and Murphy M. (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277, 3247-257.
12. International Union Against Cancer I.U.C.C. (2000). TNM classification of malignant tumours. 6th. ed. Wiley-Liss. New York.
13. Jackman M., Lindon C., Nigg E.A. and Pines J. (2003). Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell Biol. 5, 143-148.
14. Jessus C. and Ozon R. (1995). Function and regulation of cdc25 protein phosphate through mitosis and meiosis. Prog. Cell Cycle Res. 1, 215-228.
15. Jin S., Tong T., Fan W., Fan F., Antinore M.J., Zhu X., Mazzacurati L., Li X., Petrik K.L., Rajasekaran B., Wu M. and Zhan Q. (2002). GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene 21, 8696-8704.
16. Kim M.J., Lim K.Y., Kim J.W., Nam I.W., Lee J.H. and Myoung H. (2005). Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma. Cancer Lett. 224, 253-261.
17. Kinoshita Y., Dohi M., Mizutani N. and Ikeda A. (1996). Effects of preoperative radiation and chemotherapy on AgNOR counts in oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 54, 304-7 discussion 307-308.
18. Kumagai A. and Dunphy W.G. (1999). Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev. 13, 1067-1072.
19. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C. and Altieri D.C. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
20. Lin C.Y., Hung H.C., Kuo R.C., Chiang C.P. and Kuo M.Y. (2005). Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol. 41, 645-654.
21. Lo Muzio L., Staibano S., Pannone G., Mignogna M.D., Mariggio A., Salvatore G., Chieffi P., Tramontano D., De Rosa G. and Altieri D.C. (2001). Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp. Mol. Pathol. 70, 249-254.
22. Lo Muzio L., Pannone G., Leonardi R., Staibano S., Mignogna M.D., De Rosa G., Kudo Y., Takata T. and Altieri D.C. (2003a). Survivin, a potential early predictor of tumor progression in the oral mucosa. J. Dent. Res. 82, 923-928.
23. Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Rubini C., Mariggio M.A., Procaccini M., Ferrari F., De Rosa G. and Altieri D.C. (2003b). Survivin expression in oral squamous cell carcinoma. Br. J. Cancer. 89, 2244-2248.
24. Lo Muzio L., Campisi G., Giovannelli L., Ammatuna P., Greco I., Staibano S., Pannone G., De Rosa G., Di Liberto C. and D'Angelo M. (2004). HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol. 40, 736-741.
25. Lo Muzio L., D'Angelo M., Procaccini M., Bambini F., Calvino F., Florena A.M., Franco V., Giovannelli L., Ammatuna P. and Campisi G. (2005a). Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks. Int. J. Cancer 115, 717-723.
26. Lo Muzio L., Farina A., Rubini C., Pezzetti F., Stabellini G., Laino G., Santarelli A., Pannone G., Bufo P., de Lillo A. and Carinci F. (2005b). Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett. 225, 27-33.
27. Marusawa H., Matsuzawa S., Welsh K., Zou H., Armstrong R., Tamm I. and Reed J.C. (2003). HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22, 2729-2740.
28. Mirza N.M., Mohimen A. and Ahmed A.R. (1990). Detection of pemphigus vulgaris antigen on COLO and SCaBER tumor cell lines by the immunoblot technique. Arch. Dermatol. Res. 282, 418-420.
29. O'Connell M.J. and Cimprich K.A. (2005). G2 damage checkpoints: what is the turn-on? J. Cell Sci. 118, 1-6.
30. cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 97, 13103-13107.
31. O'Connor D.S., Schechner J.S., Adida C., Mesri M., Rothermel A.L., Li F., Nath A.K., Pober J.S. and Altieri D.C. (2000b). Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol. 156, 393-398.
32. O'Connor D.S., Wall N.R., Porter A.C. and Altieri D.C. (2002). A p34(cdc2) survival checkpoint in cancer. Cancer Cell. 2, 43-54.
33. Park J.W., Choi Y.J., Suh S.I., Baek W.K., Suh M.H., Jin I.N., Min D.S., Woo J.H., Chang J.S., Passaniti A., Lee Y.H. and Kwon T.K. (2001). Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 22, 1633-9.
34. Pindborg J.J., Reichart P.A., Smith C.J. and van der Waal I. (1997). Histological typing of cancer and precancer of the oral mucosa. World Health Organization International Histological Classification of Tumors. Springer-Verlag. Berlin Heidelberg New York. pp 9-29.
35. Pines J. and Hunter T. (1991). Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell Biol. 115, 1-17.
36. Saito T., Sugiura C., Hirai A., Notani K., Totsuka Y., Shindoh M. and Fukuda H. (2001). Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int. J. Oral Maxillofac. Surg. 30, 49-53.
37. Saxena A., Yashar C., Taylor D.D. and Gercel-Taylor C. (2005). Cellular response to chemotherapy and radiation in cervical cancer. Am. J. Obstet. Gynecol. 192, 1399-1403.
38. Song Z., Yao X. and Wu M. (2003). Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis. J. Biol. Chem. 278, 23130-23140.
39. Tanaka C., Uzawa K., Shibahara T., Yokoe H., Noma H. and Tanzawa H. (2003). Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J. Dent. Res. 82, 607-611.
40. Yuan J., Yan R., Kramer A., Eckerdt F., Roller M., Kaufmann M. and Strebhardt K. (2004). Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 23, 5843-5852.
41. Zhou M., Gu L., Li F., Zhu Y., Woods W.G. and Findley H.W. (2002). DNA Damage Induces a Novel p53-Survivin Signaling Pathway Regulating Cell Cycle and Apoptosis in Acute Lymphoblastic Leukemia Cells. J. Pharmacol. Exp. Ther. 303, 124-1231.